Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield blood test

09.05.2023 - Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today presented additional data from the ECLIPSE study at 2023 Digestive Disease Week (DDW) titled, “Clinical Validation of a Cell-Free DNA Blood-Based Test for Colorectal ... Seite 1

Related Keywords

Massachusetts ,United States ,Americans ,American ,Daniel Chung ,Professor Of Medicine At Harvard Medical School ,Massachusetts General Hospital ,Harvard Medical ,Asian American ,Black Americans ,Guardant Health ,